Collagen Structure, Folding and Function - Osteogenesis Imperfecta - page 77

[165] Kuivaniemi H, Tromp G, Prockop DJ. Mutations in collagen

genes: causes of rare and some common diseases in humans.
Faseb J 1991;5(7):2052-60.

[169] Sweeney SM, Orgel JP, Fertala A, McAuliffe JD, Turner KR, Di

Lullo GA, et al. Candidate cell and matrix interaction domains
on the collagen ibril, the predominant protein of vertebrates.
J Biol Chem 2008;283(30):21187-97. [166] Cabral WA, Milgrom S, Letocha AD, Moriarty E, Marini JC.

Biochemical screening of type I collagen in osteogenesis imper-
fecta: detection of glycine substitutions in the amino end of the
alpha chains requires supplementation by molecular analysis.
J Med Genet 2006;43(8):685-90.

[170] Marini JC, Lewis MB, Wang Q, Chen KJ, Orrison BM. Serine

for glycine substitutions in type-I collagen in 2 cases of type-IV
osteogenesis imperfecta (OI) - additional evidence for a regional
model of OI pathophysiology. J Biol Chem 1993;268(4):2667-73.

[167] Bachinger HP, Morris NP, Davis JM. Thermal stability and fold-

ing of the collagen triple helix and the effects of mutations in
osteogenesis imperfecta on the triple helix of type I collagen.
Am J Med Genet 1993;45(2):152-62.

[171] Hidvegi T, Mirnics K, Hale P, Ewing M, Beckett C, Perlmutter

DH. Regulator of G signaling 16 is a marker for the distinct
encloplasmic reticulum stress state associated with aggregated
mutant alpha(1)-antitrypsin Z in the classical form of alpha(1)-
antitrypsin deiciency. J Biol Chem 2007;282(38):27769-80. [168] Di Lullo GA, Sweeney SM, Korkko J, Ala-Kokko L, San

Antonio JD. Mapping the ligand-binding sites and disease-
associated mutations on the most abundant protein in the
human, type I collagen. J Biol Chem 2002;277(6):4223-31.